Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 19.45 -0.30 (-1.53%)
As of 10/15/2025 12:03 PM Eastern

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, PRTC, NIOX, and HZD

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), PureTech Health (PRTC), NIOX Group (NIOX), and Horizon Discovery Group plc (HZD.L) (HZD). These companies are all part of the "medical" sector.

BATM Advanced Communications vs. Its Competitors

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£118.82M0.71-£278.26K-£0.06-326.31
Tristel£43.56M3.94£6.54M£0.132,790.70

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
Tristel 15.47%20.43%9.89%

BATM Advanced Communications has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500.

12.8% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 37.8% of Tristel shares are held by institutional investors. 23.7% of BATM Advanced Communications shares are held by company insiders. Comparatively, 21.1% of Tristel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Tristel has a consensus target price of GBX 400, indicating a potential upside of 11.11%. Given Tristel's stronger consensus rating and higher possible upside, analysts plainly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Tristel had 5 more articles in the media than BATM Advanced Communications. MarketBeat recorded 5 mentions for Tristel and 0 mentions for BATM Advanced Communications. Tristel's average media sentiment score of 1.32 beat BATM Advanced Communications' score of 0.58 indicating that Tristel is being referred to more favorably in the news media.

Company Overall Sentiment
BATM Advanced Communications Positive
Tristel Positive

Summary

Tristel beats BATM Advanced Communications on 12 of the 15 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£84.93M£2.76B£6.11B£2.59B
Dividend Yield3.52%2.04%5.73%5.32%
P/E Ratio-326.31266.9885.364,418.40
Price / Sales0.7194.15601.96101,543.57
Price / Cash2.12146.5437.4627.90
Price / Book0.832.3712.428.24
Net Income-£278.26K£99.80M£3.32B£5.89B
7 Day Performance-0.78%31.20%0.57%-0.06%
1 Month Performance18.59%30.27%10.52%2.41%
1 Year Performance5.98%161.44%72.99%138.98%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 19.45
-1.5%
N/A+2.4%£84.93M£118.82M-326.31980
TSTL
Tristel
1.0833 of 5 stars
GBX 363
+0.8%
GBX 400
+10.2%
+1.4%£173.24M£43.56M2,813.95208Positive News
Earnings Report
SPEC
INSPECS Group
N/AGBX 47.10
-2.9%
GBX 60
+27.4%
-20.0%£47.89M£195.28M-584.371,673Gap Up
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 2.81
+0.4%
N/AN/A£6.69M£8.33M401.713,200Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
3.873 of 5 stars
GBX 240
+0.4%
GBX 309.40
+28.9%
+3.7%£4.82B£2.36B2,264.1510,000
AMS
Advanced Medical Solutions Group
2.3863 of 5 stars
GBX 227
+2.5%
GBX 273.67
+20.6%
+9.0%£490.73M£220.30M5,443.6510
PRTC
PureTech Health
N/AGBX 134.80
-1.6%
GBX 455
+237.5%
-14.8%£325.79M£6.17M792.94300
NIOX
NIOX Group
N/AGBX 74
flat
GBX 90
+21.6%
+14.1%£309.23M£46M5,920.0092
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416

Related Companies and Tools


This page (LON:BVC) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners